Astrazeneca

Latest Articles

Daily Agenda: Oil Prices Fall on Robust Supply

Andrew Barber August 24, 2016

Investing in a Cure for Cancer

Kaitlin Ugolik June 7, 2016

Daily Agenda: The Fed Connects the Dots

Andrew Barber December 17, 2015

Daily Agenda: December Hike Rumors Don’t Deter Bond Buying

Andrew Barber November 6, 2015

MIT’s Andrew Lo Touts Megafund to Tackle Cancer, Rare Diseases

Kaitlin Ugolik October 26, 2015

Tech Banker Ken Olisa Champions Good Corporate Governance

Jess Delaney July 20, 2015

Premium

Funds Benefit from Merger-Happy Health Care Stocks

Stephen Taub June 23, 2015

Ben Thorpe Helps Keep Goldman’s Health M&A Franchise in Top Shape

David Rothnie June 22, 2015

Pfizer And AstraZeneca's Billion Dollar Battle

In Event-Driven Strategy Hedge Funds, M&A is the Headliner

David Turner May 13, 2014

The New Logic of M&A

Joseph G Paul May 8, 2014

AstraZeneca Puts $100M More Into VC Unit

November 29, 2011

AstraZeneca To Raise Share Buyback By $1B

July 28, 2011

Henderson Manager Favors Pharma

May 29, 2011

Astra Tech To Get $850M Buyout Loan

March 17, 2011

PE Firms Eye $2B Astra Tech Auction

February 25, 2011

Eurex To List Futures On U.K. Equities

February 14, 2011

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

4.12.03 build:2025-12-12 Login